CVS Health (CVS) Tops Q4 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $88.51 --0%
EPS Growth %: +3.1%
Financial Fact:
Net revenues: 44.62B
Today's EPS Names:
IEP, XPRO, GEF, More
EPS Growth %: +3.1%
Financial Fact:
Net revenues: 44.62B
Today's EPS Names:
IEP, XPRO, GEF, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $1.19, $0.19 better than the analyst estimate of $1.00. Revenue for the quarter came in at $97.7 billion versus the consensus estimate of $96.97 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $5.75-$6.00, versus the consensus of $5.97.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yum China (YUMC) Tops Q3 EPS by 3c
- Aletheia Capital Reiterates Sell Rating on Apple (AAPL), PT $250, 'we expect both gross and operating margins to contract'
- Philips (PHG) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
